A

Andlauer Healthcare Group Inc
TSX:AND

Watchlist Manager
Andlauer Healthcare Group Inc
TSX:AND
Watchlist
Price: 54.97 CAD 0.02%
Market Cap: 2.2B CAD

Andlauer Healthcare Group Inc
Investor Relations

Andlauer Healthcare Group Inc. operates within the specialized realm of healthcare logistics and transportation, commanding its niche with precision and efficiency. Founded in 1991, the company has carved a distinct position in the Canadian market, known for its tailored solutions that meet the complex demands of the healthcare sector. From pharmaceutical companies to biotechnology firms, Andlauer serves clients who rely on the timely and secure transportation of sensitive healthcare products. With a network of temperature-controlled transportation and warehousing facilities, the company ensures that critical shipments maintain their integrity throughout their journey. This specialization not only supports the compliance needs of their customers but also positions Andlauer as an indispensable partner in the healthcare supply chain.

Revenue generation for Andlauer primarily stems from its comprehensive suite of logistics and transportation services, which are tailored specifically for the nuances of the healthcare industry. By offering end-to-end solutions that encompass distribution, specialized transport, and dedicated warehousing, the company captures diverse streams of income within this highly regulated sector. Additional value comes from their technology-driven approach, harnessing data and analytics to optimize routing and improve supply chain visibility. Through strategic acquisitions and partnerships, Andlauer continues to expand its footprint, enhancing service capabilities and geographical reach. This calculated growth strategy not only solidifies its market leadership but also fortifies its financial performance in a rapidly evolving industry landscape.

Show more
Loading
AND
S&P TSX Composite Index (Canada)
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q4 2024
Call Date
Feb 27, 2025
AI Summary
Q4 2024

Record Revenue: Andlauer Healthcare Group reported record annual revenue of $650.5 million, driven by strong growth in Canadian operations.

Margin Stability: EBITDA margin for the year was 25.3%, in line with the company’s target range of 24%–26%.

Canadian Growth: Canadian Ground Transportation revenue (excluding fuel) rose 6.3% in Q4, offsetting weakness in U.S. operations.

U.S. Headwinds: U.S.-based truckload revenue dropped 17% in Q4, with EBITDA from Boyle Transportation and Skelton USA down $2.5 million year-over-year.

Packaging Turnaround: Packaging Solutions revenue was up 25% year-over-year in Q4, showing signs of momentum with client demand.

EPS Growth: Diluted earnings per share for the year increased to $1.58 from $1.55 last year, boosted by share buybacks.

Dividend Increase: Quarterly dividend was raised to $0.12 per share.

CapEx Guidance: 2025 capital expenditures expected to be consistent with 2024, around $17.6 million to under $20 million, split roughly 50-50 between maintenance and growth.

Solid Outlook: Management expects organic growth in Canada to continue at mid- to high-single-digit rates, with U.S. operations stabilizing by year-end.

Key Financials
Revenue
$650.5 million
EBITDA Margin
25.3%
Earnings Per Share (Diluted)
$1.58
Quarterly Dividend
$0.12 per share
Healthcare Logistics Revenue (Q4)
$48.7 million
Specialized Transportation Revenue (Q4)
$119.6 million
Ground Transportation Revenue (Q4)
$108.8 million
EBITDA (Q4)
$43.6 million
EBITDA Margin (Q4)
25.9%
Operating Income (Q4)
$26.7 million
Net Income (Q4)
$17.5 million
Earnings Per Share (Q4, diluted)
$0.44
Air Freight Forwarding Revenue (Q4)
$8.3 million
Dedicated and Last Mile Delivery Revenue (Q4)
$19 million
Cost of Transportation and Services (Q4)
$83.5 million
Direct Operating Expenses (Q4)
$27.6 million
Cash and Cash Equivalents (Year-end)
$40.5 million
Working Capital (Year-end)
$62.7 million
Term Facility Outstanding (Year-end)
$25 million
Revolving Facility Drawn (Year-end)
$30 million
Net Leverage Ratio
0.86
NCIB Shares Repurchased (Year-end)
266,000+ shares
NCIB Buyback Amount (Year-end)
$10.4 million
Capital Expenditures (2024)
$17.6 million
Earnings Call Recording
Other Earnings Calls

Management

Mr. Michael N. Andlauer
CEO & Director
No Bio Available
Mr. Peter Bromley C.A., CPA
CFO & Corporate Secretary
No Bio Available
Mr. Charles Robert Brogan
President of Specialty Solutions
No Bio Available
Mr. Dean Berg
President of Logistics
No Bio Available
Mr. Graham Cromb
Chief Strategy Officer
No Bio Available
Mr. Sandro Caccaro
President of Transportation
No Bio Available

Contacts

Address
ONTARIO
Vaughan
100 Vaughan Valley Blvd.
Contacts